FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI

Peer Review reports

Original Submission
24 Sep 2020	Submitted	Original manuscript
16 Oct 2020	Reviewed	Reviewer Report
21 Oct 2020	Reviewed	Reviewer Report
7 Dec 2020	Author responded	Author comments - Tingting Song
Resubmission - Version 2
7 Dec 2020	Submitted	Manuscript version 2
8 Dec 2020	Reviewed	Reviewer Report
11 Dec 2020	Reviewed	Reviewer Report
15 Dec 2020	Author responded	Author comments - Tingting Song
Resubmission - Version 3
15 Dec 2020	Submitted	Manuscript version 3
22 Dec 2020	Reviewed	Reviewer Report
22 Dec 2020	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
25 Dec 2020	Editorially accepted
7 Jan 2021	Article published	10.1186/s12872-020-01839-w

Back to article page